本页面由Tiger Trade Technology Pte. Ltd.提供服务

Impact Biomedical, Inc.

0.5906
-0.0232-3.78%
盘后0.60740.0168+2.84%19:53 EDT
成交量:4.41万
成交额:2.55万
市值:6,378.48万
市盈率:-1.55
高:0.6097
开:0.5794
低:0.5550
收:0.6138
52周最高:1.95
52周最低:0.3621
股本:1.08亿
流通股本:1,163.81万
量比:0.34
换手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-0.3800
每股收益(LYR):-0.3800
净资产收益率:-104.16%
总资产收益率:-14.16%
市净率:5.06
市盈率(LYR):-1.55

数据加载中...

2024/09/17

重要事件披露

Form 8-K - Current report
2024/09/09

SEC问询函

Form CORRESP - Correspondence
2024/09/09

SEC问询函

Form CORRESP - Correspondence
2024/09/05

SEC问询函

Form CORRESP - Correspondence
2024/09/05

SEC问询函

Form CORRESP - Correspondence
2024/09/03

SEC问询函

Form CORRESP - Correspondence
2024/09/03

SEC问询函

Form CORRESP - Correspondence
2024/08/27

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

SEC问询函

Form CORRESP - Correspondence
2024/08/12

SEC问询函

Form CORRESP - Correspondence
2024/08/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/08

SEC问询函

Form CORRESP - Correspondence
2024/08/08

SEC问询函

Form CORRESP - Correspondence
2024/06/11

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]